Search research articles
Contact Us
Filters
Showing results (131-140 of 347) with videos related to
Page
of 35
Sort By:
Expert Review of Vaccines
|
October 25, 2023
Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination
Ruyun Gao, Cuiling Zheng, Mengwei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Multi-Omics and Single-Cell Insights Reveal a Lysophosphatidic Acid (LPA)-Mediated Resistant Mechanism to Third Generation EGFR-TKI in Non-Small Cell Lung Cancer
Ruyun Gao, Ning Lou, Sheng Yang, et al.
Chest
|
October 10, 2018
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
Zhenguo Zhai, Quancheng Kan, Weimin Li, et al.
Mabs
|
November 6, 2010
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
Chong Wang, Xiaohui He, Bo Zhou, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
May 24, 2014
[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma]
Yutao Liu, Yuankai Shi, Xingsheng Hu, et al.
Chemotherapy
|
January 5, 2007
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study
Yuankai Shi, Xiaohui He, Sheng Yang, et al.
American Journal of Cancer Research
|
May 5, 2021
<i>SLF1</i> polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer
Xiaohong Han, Zheng Wang, Lei Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 23, 2016
[Duration of filgrastim prophylaxis for chemotherapy-induced neutropenia and its predictors]
Sheng Yang, Xiaohui He, Peng Liu, et al.
The Oncologist
|
April 7, 2020
A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
Yutao Liu, Xingsheng Hu, Jun Jiang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 17, 2017
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia
Yan Qin, Xiaohong Han, Lin Wang, et al.
Page
of 35
Search research articles
Search
Showing results (131-140 of 347) with videos related to
Sort By:
Page
of 35
Expert Review of Vaccines
|
October 25, 2023
Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination
Ruyun Gao, Cuiling Zheng, Mengwei Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Multi-Omics and Single-Cell Insights Reveal a Lysophosphatidic Acid (LPA)-Mediated Resistant Mechanism to Third Generation EGFR-TKI in Non-Small Cell Lung Cancer
Ruyun Gao, Ning Lou, Sheng Yang, et al.
Chest
|
October 10, 2018
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
Zhenguo Zhai, Quancheng Kan, Weimin Li, et al.
Mabs
|
November 6, 2010
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
Chong Wang, Xiaohui He, Bo Zhou, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
May 24, 2014
[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma]
Yutao Liu, Yuankai Shi, Xingsheng Hu, et al.
Chemotherapy
|
January 5, 2007
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study
Yuankai Shi, Xiaohui He, Sheng Yang, et al.
American Journal of Cancer Research
|
May 5, 2021
<i>SLF1</i> polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer
Xiaohong Han, Zheng Wang, Lei Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 23, 2016
[Duration of filgrastim prophylaxis for chemotherapy-induced neutropenia and its predictors]
Sheng Yang, Xiaohui He, Peng Liu, et al.
The Oncologist
|
April 7, 2020
A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
Yutao Liu, Xingsheng Hu, Jun Jiang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 17, 2017
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia
Yan Qin, Xiaohong Han, Lin Wang, et al.
Page
of 35